Lungpacer News & Media
Stay up to date with the latest breakthroughs,
research, and company milestones
Lungpacer Press Release
Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again.
Read The Article
Lungpacer News
Health-Economic Value of Transvenous Diaphragm Neurostimulation in Ventilator Weaning
Read The Article
Lungpacer Press Release
Lungpacer Announces Health Economic Analysis Demonstrating Clinical and Cost Benefits of AeroPace in Mechanically Ventilated Patients
Read The Article
Lungpacer Press Release
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
Read The Article
Sort by:
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
February 20, 2025
Press Release
Lungpacer Medical Announces Premarket Approval for AeroPace® System
December 5, 2024
Press Release
Lungpacer Medical Announces PMA Submission for AeroPace® System
September 4, 2024
Press Release
Doug Evans and Lungpacer Medical announce receipt of the 2022 Pulse-Setter Champion Award from the Cardiovascular Research Foundation for innovative uses of emerging technologies to help patients
December 9, 2022
News
Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System
February 14, 2022
Press Release
Lungpacer Medical, Inc. Announces Publication of RESCUE 2 Study Design Manuscript
December 1, 2019
Press Release
Lungpacer Medical, Inc. Announces Enrollment of First Subject in RESCUE 3 Clinical Study
June 14, 2019
Press Release
Lungpacer Medical, Inc. Announces the Opening of US Headquarters
January 1, 2018
News
Steve Reynolds, MD, to Present Encouraging Preclinical Results with Lungpacer Medical’s Catheter-based Diaphragm Pacing System
May 18, 2015
Press Release
